WinMedica Pharmaceutical

📍 Marousi, Greece🗓 Founded 2008👥 180 employees💰 Last funded Jan 2024
Win Medica, headquartered in northern Athens, Greece, is committed to advancing patient care and improving quality of life. We operate across major therapeutic areas including Cardiometabolics, Oncology, Hematology and Immunology. Our strategic collaborations in Greece and internationally with leading multinational pharmaceutical companies enable us to address critical patient needs and expand access to both established and innovative therapeutic solutions. Win Medica is also advancing its capabilities with the development of a state-of-the-art R&D center and manufacturing facility in Tripoli, Greece. This site will focus on the production of high-potent therapies that require exceptional precision, quality and stringent containment standards.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2008
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Greece
1
Frequently asked questions
Who invested in WinMedica Pharmaceutical?
WinMedica Pharmaceutical has 1 investors on record on gritt.io.
When did WinMedica Pharmaceutical last raise funding?
The most recent investment in WinMedica Pharmaceutical recorded on gritt.io was in January 2024.
When was WinMedica Pharmaceutical founded?
WinMedica Pharmaceutical was founded in 2008.
What industry is WinMedica Pharmaceutical in?
WinMedica Pharmaceutical operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is WinMedica Pharmaceutical based?
WinMedica Pharmaceutical is headquartered in Marousi, Greece.